interleukin-6

GPTKB entity

Statements (60)
Predicate Object
gptkbp:instance_of gptkb:vaccine
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:siltuximab
gptkbp:activities muscle cells
fat cells
liver cells
gptkbp:associated_with gptkb:healthcare_organization
autoimmune diseases
chronic inflammatory diseases
gptkbp:enhances T cell activation
B cell differentiation
gptkbp:established apoptosis
gptkbp:has_part gptkb:healthcare_organization
gptkb:Company
gptkb:psychologist
gptkb:rheumatoid_arthritis
sepsis
https://www.w3.org/2000/01/rdf-schema#label interleukin-6
gptkbp:influences neurotransmitter release
bone metabolism
hematopoiesis
gptkbp:is_aimed_at gptkb:tocilizumab
gptkb:siltuximab
sarilumab
gptkbp:is_involved_in gptkb:asthma
gptkb:healthcare_organization
gptkb:psychologist
cell differentiation
cell growth
cell signaling
immune response
allergic reactions
chronic pain
fever
inflammation
metabolic syndrome
obesity
wound healing
stress response
cardiovascular diseases
fungal infections
pain perception
sleep regulation
immune tolerance
aging process
tissue repair
viral infections
bacterial infections
transplant rejection
chronic obstructive pulmonary disease
muscle wasting
parasitic infections
acute phase response
cachexia
COVID-19 pathology
gptkbp:measures blood tests
gptkbp:produced_by gptkb:T_cells
macrophages
gptkbp:promotes angiogenesis
gptkbp:regulates metabolism